Obviously This most recent share price erosion is in advance of GMP validation.
My concern is with what will happen in March once the fact that BNC soon controls the Urocidin platform actually sinks in. I anticipate further decline, possibly into the mid single digits.
from there Gmp validation and a full submission to HC with Urocidin should propel BNC back into the mid teens, by early summer...cents that is.